Showing 10 Clinical Trials

Full Cycles

This study will examine the pregnancy experiences of women from rural southeastern Missouri and how women navigate a changing reproductive, maternal, and pelvic health landscape.

Reading words and nonwords

The study will look at how individuals of varying reading skills tackle multi-syllabic words across development.

Child Reward

The proposed research assesses the development of different reward preferences, specifically assessing the response to receiving relative rewards (e.g. gaining at the expense of others) compared to absolute rewards (e.g. money/points earned) and the influence of parent responses on their children.

Term EMMI

The purpose of the study is to develop a safe, non-invasive technology capable of assessing contraction patterns in the uterus during labor.

DORA and LP

The purpose of the study is to see if an investigational treatment will decrease proteins in the body that are associated with Alzheimer's.

SToP-AD

The purpose of the study is to see if using an investigational medication will increase sleep and decrease the amount of amyloid beta in the brain. Amyloid-beta is a protein associated with Alzheimer's disease.

Corpus Callosum Disorders Research

The purpose of the study is to investigate differences in brain connectivity, functionality, and cognitive outcomes in individuals with corpus callosum disorders (CCD) relative to the neurotypical population in order to determine the role of the corpus callosum in high level cognition.

VAT Dystonia

The purpose of the study is to better understand the brain mechanisms that contribute to isolated dystonia, which may provide a rationale for new treatments.

CKD-MBD in the DPN Foot

The purpose of this study is to understand how the kidney function is related to quality and amount of bone in the foot in participants with type 2 diabetes.

LLP2A_PartB

The primary purpose of this imaging research study is to test the safety and tolerability of an investigational PET imaging agent in healthy volunteers and patients with blood cancers (multiple myeloma and lymphoma)